Jun. 15 at 12:48 AM
1m
$NAGE Is this number real regarding the number of people with Long COVID in the US? If so, how can the long-over-due results from the Phase 4 LC trial in Massachusetts not greatly increase Niagen and Niagen Plus sales? I am almost sure that the trial will show positive results for at lesst some participants. Sell 1000 mg per month to 2 million (10% of them in the US alone) and the SP could be 12 months at
$50 net profit x 2,000,000 =
$1.3 billion divided by 90,000,000 shares =
$13.33. net profit per share x 15 PE =
$195.50 SP. And, there is so much more ahead, like Parkinson's disease. "Long COVID Keeps People Out of Work and Hurts the ...
Yale Medicine
yalemedicine.org/ › news › long-covid-kee...
Dec 23, 2024 — Now, on top of all that, there are 20 million Americans who have Long COVID.” Ultimately, a coordinated global research agenda focused on Long ...
